EFFECT OF SURFACTANT STRUCTURE ON THE RELEASE OF DEXAMETHAZONE FROM DIFFERENT OINTMENT BASES

IN VITRO RELEASE OF SULCONAZOLE NITRATE FROM OINTMENT BASES

IN VITRO RELEASE OF DIAZEPAM FROM DIFFERENT SUPPOSITORY FORMULATIONS

EFFECT OF DIFFERENT NON IONIC SURFACTANTS ON THE IN-VITRO RELEASE RATE OF A NON STEROIDAL ANTI-INFLAMMATORY DRUG FROM SOME LIPOPHILIC SUPPOSITORY BASES

A CAST FILM APPROACH TO THE STUDY OF IN-VITRO DRUG RELEASE FROM OINTMENTS AND CREAMS

FORMULATION AND EVALUATION OF CERTAIN ANTI-INFLAMMATORY DRUGS FOR TOPICAL APPLICATION. 1- OINTMENT FORMS

RELEASE AND RHEOLOGICAL CHARACTERISTICS OF CHLORTETRACYCLINE HYDROCHLORIDE OPHTHALMIC OINTMENTS

CONTROLLED-RELEASE PREDNISOLONE POLY (DL-LACTIDE) MICROSPHERES: IMPACT OF FORMULATION PARAMETERS, CHARACTERIZATION AND RELEASE MECHANISM

FORMULATION AND EVALUATION OF CERTAIN ANTI-INFLAMMATORY DRUGS FOR TOPICAL APPLICATION. II: POLYMER FILM FORMS

Formulation and Evaluation of Prednisolone Acetate Microemulsion Ocular Gel